This brand name is authorized in Nigeria
The drug FRAMOPTIC-D contains a combination of these active pharmaceutical ingredients (APIs):
1
Framycetin
UNII Y3720KZ4TQ - FRAMYCETIN SULFATE
|
|
2
Dexamethasone
UNII AI9376Y64P - DEXAMETHASONE SODIUM PHOSPHATE
|
Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. |
3
Gramicidin
UNII 5IE62321P4 - GRAMICIDIN
|
Gramicidin is an antimicrobial cyclic polypeptide active in vitro against many gram positive bacteria like Bacillus subtilis and Staphylococcus aureus, but not well against gram-negative ones like E.coli. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
S03CA01 | Dexamethasone and antiinfectives | S Sensory organs → S03 Ophthalmological and otological preparations → S03C Corticosteroids and antiinfectives in combination → S03CA Corticosteroids and antiinfectives in combination |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: NG | Registered Drug Product Database | Identifier(s): 04-3468 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.